As a globally operating company headquartered in Germany, CHEPLAPHARM has established a leading and sustainable platform for specialty pharma during the past two decades. We invest worldwide in well-established pharmaceutical brands which have been developed and introduced by research-based pharmaceutical companies. Our deep expertise in this field enables us to sustain the value of these brands for patients and the medical community. In this way we help the research-based pharmaceutical industry divest from older products so they can focus resources on innovation and new product pipelines. This is how we ACHIEVE MORE together.
Looking for a particular CHEPLAPHARM employee's phone or email?
CHEPLAPHARM Questions
The CHEPLAPHARM annual revenue was $1.6 billion in 2026.
Martin Kraemer is the CFO of CHEPLAPHARM.
347 people are employed at CHEPLAPHARM.
CHEPLAPHARM is based in Greifswald, Mecklenburg-Vorpommern.
The NAICS codes for CHEPLAPHARM are [325, 3254, 32, 32541].
The SIC codes for CHEPLAPHARM are [28, 283].
Top CHEPLAPHARM Employees
-
Martin Kraemer
CFO at CHEPLAPHARM
Bad Homburg, HE, DE31 -
Kia Parssanedjad
Chief Financial Officer (CFO) at CHEPLAPHARM
Bavaria, Germany2 -
12
-
32
-
Bianca Juha
Chief Scientific Officer at CHEPLAPHARM
Greifswald, MV, DE1 -
Sandra Schröder
VP, Global Head of Science at CHEPLAPHARM
Binningen, BL, CH1
Related Companies
